Michael Saylor Teases Another Bitcoin Purchase As MSTR Stock Price Rebounds
Michael Saylor has indicated that another Bitcoin buy will be made with Strategy holding over 3% of the entire supply. This comes
Michael Saylor has indicated that another Bitcoin buy will be made with Strategy holding over 3% of the entire supply. This comes
The search to fill the Fed position when the current chair leaves is moving to Wall Street. President Donald Trump has indicated
The European Union stated that it intends to take strong measures against the United States in response to the new Tariffs imposed
Bitcoin price fell more than 3% to a low of $92,089 in Asia trading hours, primarily due to new Trump tariffs on
The crypto market opens this week with a cautious note as the odds of the Federal Reserve’s interest rate cut plunge significantly.
COIN stock saw a significant rebound this year following a 42% decline after the October 10 crypto market crash. However, recent tariff
U.S spot Bitcoin ETFs have made a remarkable comeback in the market since the new year started. They saw their best weekly
Cardano founder Charles Hoskinson has publicly criticized Ripple CEO Brad Garlinghouse for supporting the CLARITY Act in its current form. This comes
AST SpaceMobile (NASDAQ: ASTS) pushed meaningfully higher to print a record high of nearly $120 this morning after being picked as a
Tonight’s digest tracks the accelerating use of trade and tariffs as geopolitical leverage, from Trump’s renewed pressure campaign over Greenland to Canada’s
US stocks ticked higher at midday Friday as the S&P 500 climbed 0.3%, the Nasdaq advanced 0.4%, and the Dow Jones Industrial
“GLP-1 drugs don’t just change what people eat,” Karthik Srinivasan, communications strategy consultant, tells Invezz.They change whether people want to eat at
Indian stocks, especially the nation’s tech sector, will likely face turbulence in the first half of 2026, according to Amish Shah, a
The Trump administration on Thursday unveiled what it called the “Great Healthcare Plan,” a broad framework aimed at addressing healthcare affordability, drug